Serotonin antagonists for use as antiglaucoma agents and their ocular penetration

Author： Schoenwald R.D.   R. Gadiraju R.   Barfknecht C.F.  

Publisher： Elsevier

ISSN： 0939-6411

Source： European Journal of Pharmaceutics and Biopharmaceutics, Vol.43, Iss.3, 1997-06, pp. : 273-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Common Topical Antiglaucoma Medications on the Ocular Surface, Eyelids and Periorbital Tissue

By Servat J. Javier  

Drugs & Aging, Vol. 28, Iss. 4, 2011-04 ,pp. : 267-282

Adis International

Access to resources Recommend Favorite

Betaxolol Hydrochloride Loaded Chitosan Nanoparticles for Ocular Delivery and their Anti-glaucoma Efficacy

By  

Current Drug Delivery, Vol. 10, Iss. 5, 2013-10 ,pp. : 493-499

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment

By  

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 978-993

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Topically Acting Carbonic Anhydrase Inhibitors as Antiglaucoma Agents

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-05 ,pp. : 849-854

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Topically Acting Carbonic Anhydrase Inhibitors as Antiglaucoma Agents

By  

Current Pharmaceutical Design, Vol. 14, Iss. 7, 2008-03 ,pp. : 649-654

Bentham Science Publishers

Access to resources Recommend Favorite